PHARMACEUTICAL PERFORMANCE IN THE EVALUATION AND ADHERENCE TO PHARMACOLOGICAL TREATMENT OF TYPE 2 DIABETES MELLITUS. REMUNOM. 2025;9(1):1-13. doi:10.61164/rmnm.v9i1.3911